The move comes more than 10 months after the state's governor first called for selling non-compliant plans.
Idaho insurance officials have decided not to wait for CMS and are letting insurers sell health plans that don’t fully comply with the Affordable Care Act (ACA). The controversial step comes almost a year after the state’s governor called for selling less expensive, non-compliant plans.
It was unclear late Friday whether state-based plans are currently being sold in direct competition with ACA-complaint plans. A call to the Idaho Department of Insurance was not returned. However, a release issued Thursday as open enrollment began seemed to imply this possibility. The list of questions it encouraged consumers to ask included, “Does my plan meet all requirements of the Affordable Care Act?”
In February, Blue Cross of Idaho unveiled 5 state-based plans it hoped to sell alongside ACA-complaint plans, including those that would subject consumers to medical underwriting. CMS rejected Idaho’s approach, saying regulators would not be “substantially” enforcing the ACA. As recently as September, Insurance Department Director Dean Cameron said the state was still in talks with CMS, with one issue to resolve.
Cameron has argued that CMS is hard-pressed to reject Idaho’s decision, given the administration’s posture in a Texas lawsuit to overturn the ACA.
The state has not sought a 1332 waiver, which gives states additional flexibility under the ACA.
Idaho regulators have said that too many residents have gone without health insurance because they can’t afford prices on the ACA exchanges, but they make too much money to qualify for federal premium subsidies.
Tuesday’s election results could further change the state’s insurance market. If voters approve a ballot initiative to expand Medicaid, some consumers who might have purchased short-term plans or state-based plans could be eligible for Medicaid.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More